GL1X · GenesisL1 explorer

MolNFT v1 · #102647 · protein

Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide UK602 (bicyclic 1)

4OS2: “Crystal structure of urokinase-type plasminogen activator (upa) complexed with bicyclic peptide UK602…”. X-ray diffraction, 2 ligands (SO4, NH2), 1 pocket (best druggability 0.27). MolNFT v1 #102647 on GenesisL1: 3D structure…

PDB
4OS2
Type
protein
Length
258 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator; Bicyclic peptide UK602 (bicyclic 1)
EC
3.4.21.73
UniProt
P00749
Ligands
SO4, NH2
Pockets
1 · best druggability 0.27

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 38% strandP00749
BBicyclic peptide UK602 (bicyclic 1)protein130% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • NH2 · Amino group · ion · chains B
  • ACT · Acetate ion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.270.7314empty

Interfaces

1 interface between chains.

  • A–B · 680 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 modified (disulfide, nonstandard).

Compared structures

  • 4OS2 · Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.